Skip to main content
LUMIBIRD logo

LUMIBIRD — Investor Relations & Filings

Ticker · LBIRD ISIN · FR0000038242 LEI · 969500MLJC3ZSZP4L019 PA Manufacturing
Open in API
Filings indexed 561 across all filing types
Latest filing 2026-06-03 Regulatory Filings
Country FR France
Listing PA LBIRD

About LUMIBIRD

https://www.lumibird.com/en/

LUMIBIRD is a leading specialist in laser technologies with over 50 years of experience. The company designs and manufactures high-performance lasers based on its expertise in three key technologies: solid-state lasers, fiber lasers, and laser diodes. It operates through two primary divisions. The Photonics division provides advanced laser solutions for applications in defense, space, environmental monitoring (including Lidar sensors), industrial manufacturing, and scientific research. The Medical division offers innovative ophthalmological and medical solutions, ranging from diagnostic equipment to laser treatment systems, through brands such as Quantel Medical and Ellex.

Recent filings

Filing Released Lang Actions
Lumibird : Informations relatives au nombre total de droits de vote et d'actions au 31 mai 2026
Regulatory Filings Classification · 81% confidence The document is a statutory regulatory disclosure under French Commercial Code articles L.233-8 II and AMF Regulation 223-16, presenting the total number of shares and voting rights as of May 31, 2026. It is not an AGM presentation, vote results, financial report, or capital-raising announcement but a routine compliance notice. It therefore falls into the general Regulatory Filings (RNS) category.
2026-06-03 French
LUMIBIRD : ASSEMBLEE GENERALE MIXTE DU 28 AVRIL 2026 : RESULTATS DES VOTES
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the voting results from Lumibird’s Assemblée Générale Mixte held on 28 April 2026. It provides detailed vote counts and percentages for ordinary and extraordinary resolutions, with no substantive financial statements or presentations. This matches the profile of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-05-12 French
Lumibird : Informations relatives au nombre total de droits de vote et d'actions au 30 avril 2026
Regulatory Filings Classification · 88% confidence The document is a short regulatory notice in French providing the number of shares and voting rights pursuant to articles of the French Commercial Code and AMF General Regulation. It does not present financial statements, AGM materials, vote results from a meeting, or a detailed report; rather it is a compliance announcement. This falls under the general “Regulatory Filings” category (RNS).
2026-05-12 French
LUMIBIRD: Q1 REVENUE UP +0.7% AND +4.1% AT CONSTANT EXCHANGE RATES
Earnings Release Classification · 92% confidence The document is a press release announcing first-quarter financial results (revenue figures, growth rates, outlook), formatted as an initial earnings announcement rather than a full interim report. It provides key highlights and unaudited quarterly revenues, matching the definition of an Earnings Release (ER). Q1 2026
2026-04-27 English
LUMIBIRD : CHIFFRE D'AFFAIRES T1 EN HAUSSE DE +0,7% ET +4,1% À CHANGE CONSTANT
Earnings Release Classification · 85% confidence The document is a press release titled “COMMUNIQUE DE PRESSE” dated April 27, 2026, providing first-quarter 2026 consolidated revenue figures, divisional and geographic breakdowns, commentary, and outlook. It contains key quarterly financial highlights rather than the full interim report or detailed Excel schedules, and it does not reference a separate attached report. This format and content align with an Earnings Release (initial quarterly results announcement). Q1 2026
2026-04-27 French
LUMIBIRD MEDICAL ACCELERATES ASIA PACIFIC EXPANSION WITH FUTURE ACQUISITION OF BIZ MEDIC SDN BHD TO FORM NEW SOUTHEAST ASIAN HUB
M&A Activity Classification · 92% confidence The document is a corporate press release announcing the future acquisition of BIZ MEDIC SDN BHD by Lumibird Medical to establish a new Southeast Asian hub. This is clearly an M&A transaction announcement (acquisition), fitting the M&A Activity category rather than an earnings release, regulatory filing, or other. Therefore, the correct classification is M&A Activity (TAR).
2026-04-08 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.